View all newsletters
Receive our newsletter – data, insights and analysis delivered to you

Leading cloud companies serving the pharmaceutical industry

With many leading pharmaceutical companies growing their cloud-based jobs, our jobs tracker offers a useful insight into the industry leaders and investors. 

Cloud computing’s importance within the pharma industry has grown in recent years and shows no signs of slowing.

This has been instrumental in enabling and promoting the use of shared IT infrastructures and services to create a flexible, scalable, and on-demand IT environment in pharma and healthcare.

This has led to both growth in the use of cloud computing in pharma, but also the number of cloud companies investing in their services and providing them to pharma corporations.

Leading cloud providers include Accenture, Microsoft, Salesforce, and Oracle, with many others also vying for cloud-based business. With many of the leading pharmaceutical companies growing their cloud-based jobs, our jobs tracker offers a useful insight into who the industry leaders and investors are. 

Our GlobalData tracker lists pharmaceutical companies with the most cloud jobs posted in recent years, including industry names such as Johnson & Johnson, Merck & Co, AstraZeneca, Amgen Inc, with the tracker showing the top ten most active in the cloud-based arena.

Cloud innovation in pharma

Cloud innovation is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years.

These figures are compiled by GlobalData, all done by tracking patent filings and grants from official offices around the world.

Using detailed textual analysis, as well as official patent classifications, these are grouped into key thematic areas and linked to companies across various industries.

The figures also provide a valuable insight into the largest innovators in the sector.

Pfizer has been one of the top innovators in the pharmaceutical sector in the latest year, filing 22 related patents in the three months ending February 2022. That was up from 12 over the same period in 2021.

It was followed by the US-based Johnson & Johnson with nine patent applications, Germany-based Bayer AG (six applications), and Switzerland-based Ypsomed Holding AG (two applications).

Pharmaceutical companies and cloud computing models

Cloud computing refers to the provision of IT infrastructure and platform services to provide a flexible, scalable, and on-demand IT environment. For the fast-moving industry of pharmaceuticals, embracing cloud innovations quickly is critical.

On the most basic level, cloud computing may simply refer only to IT infrastructure such as a remotely hosted server.

In the deeper sense, it refers to a remotely hosted software application, together with all the computing elements required to provide that software such as a data centre, networking equipment, servers, storage, operating software, and security software.

Cloud computing is typically sold using the following service models:

IaaS: A model for delivering computing and storage capacity in which the consumer taps into resources that are typically hosted in a third-party facility and is charged for the volume used.

PaaS: A model for providing platform services that allows application developers to create, run, and manage applications without the complexity of building and maintaining the infrastructure typically associated with developing and launching an app.

SaaS: A subscription-based delivery mechanism for software in which the application is hosted by a third-party supplier, typically in a multi-tenant architecture, and delivered to end-users via the cloud.

Growth of cloud usage in pharma

Whether it is cost, the flexibility of use, or scalability, there are many reasons for the growing relationship between pharmaceutical companies and cloud computing.

Cloud computing provides users with an approach to consuming IT that is significantly more flexible, resource-efficient, and cost-effective compared to traditional IT.

The widespread introduction and expansion brought about by the Covid-19 response could have been problematic. If they had not invested in cloud services and innovation, many pharma businesses could well have seen their ability to work diminish as offices became vacated.

Business benefits of cloud computing for pharma companies

The cloud represents a more agile approach to operating an IT architecture, particularly in support of modernising enterprise applications. Benefits include:

Flexibility: Businesses can access IT equipment, applications, processing, and storage capacity as needed, rather than buying hardware and software assets upfront. Organisations can gain faster access to the latest application updates and other enhancements through this model.

Cost: Cloud can deliver significant cost savings across a company’s IT budget.

Cash flow: Billing is typically metered on a usage or subscription basis, so IT expenditure shifts from one-off, upfront capital expenditure to monthly operating expenses, offering a cash flow advantage.

Scalability: Computing capabilities such as storage, processing power, or network bandwidth can be scaled up almost instantly and scaled down again, depending on demand, and users are unlikely to ever be short of capacity.

Ubiquitous access: IT resources can be accessed by any authorised users on any authorised devices from any authorised location using an internet connection 

Pharma companies investing in cloud services

That investment now has the potential to transform the way some businesses operate, and pharmaceutical technology brings you all the latest information on cloud computing in pharma.

Cloud IT Services in Pharma

Cloud computing is a method for delivering information technology (IT) services in which resources are retrieved from the internet through web-based tools and applications, as opposed to a direct connection to a server.

With the massive amount of healthcare data shared globally, the cloud allows this data to be accessed easily, regardless of location.

As the global pharma and healthcare industry cloud computing market is now predicted to reach $35bn by the end of 2022, the importance of adopting it becomes obvious to leading pharma companies.

 Cloud-using companies in the pharmaceutical industry

When it comes to pharmaceutical companies and cloud computing, the improved IT agility can deliver benefits, but understanding what they may be starts with defining and comprehending what it is. This includes knowing the  thematic frameworks, cloud infrastructure, and cloud professional services that can be offered.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology